Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12200509 | 0.90 | ALDH1A1 (0.32) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL12200457 | 0.86 | ALDH1A1 (0.52) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL12200497 | 0.86 | ALDH1A1 (0.46) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL12200506 | 0.81 | ABCG2 (0.39) | ALDH1A1HPGDTSHRL3MBTL1ERBB2 | |
| SCHEMBL22144338 | 0.81 | — | — | |
| SCHEMBL13342025 | 0.80 | NPC1 (0.36) | ALDH1A1HPGDTSHRCYP1A2POLB | |
| SCHEMBL12200468 | 0.79 | ALDH1A1 (0.47) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL15890844 | 0.79 | — | — | |
| SCHEMBL12200505 | 0.79 | MEN1 (0.38) | ALDH1A1HPGDTSHRTDP1L3MBTL1 | |
| SCHEMBL12200455 | 0.76 | ALDH1A1 (0.40) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160197289-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197289-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| WO-2010067894-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | TERT, CYP1A1, NR2E3 | ALDH1A1 44/4885CYP3A4 334/4885HPGD 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.